ClinicalTrials.gg
Sign In

Blood Loss, Surgical clinical trials

The registry lists 213 studies for Blood Loss, Surgical across more than 10 countries. 40 are recruiting or about to start. 156 of them are mainly about Blood Loss, Surgical (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Blood Loss, Surgical studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
117
Recruiting
27
Status unknown
26
Terminated
15
Not yet recruiting
11
Withdrawn
9

Phase

Phase 4
40
Phase 3
36
Phase 2
18
Early Phase 1
7
Phase 1
4

Where

United States
58
Canada
21
Egypt
20
Germany
12
France
8
Italy
7

Who runs them

Assiut University (7) · HemoSonics LLC (6) · Bayer (4) · Cairo University (4) · CytoSorbents, Inc (3) · Egymedicalpedia (3) · GATT Technologies BV (3) · Ain Shams University (3)

What is being tested here

Drugs under test in Blood Loss, Surgical studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tranexamic Acid91246
Oxytocin106
Dexmedetomidine113
Carbetocin103
Ascorbic Acid101
Calcium Gluconate101
Phenylephrine101
Rocuronium101
Misoprostol036
Epinephrine014

Drug classes tested here Antifibrinolytics 9 open · Local anesthetics 3

Coming up

7phase 3 studies under way
13studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 27 Blood Loss, Surgical studies recruiting now, 10 (37%) set no upper age limit and 14 (52%) stop at 75 or younger. 6 (22%) take children under 18. 7 (26%) are for women only and 0 (0%) for men only; 4 (15%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
103 (11%)3 (11%)
1824 (89%)17 (63%)
3024 (89%)17 (63%)
4024 (89%)17 (63%)
5020 (74%)17 (63%)
6518 (67%)16 (59%)
7515 (56%)13 (48%)
8512 (44%)10 (37%)

Across all 213 studies, recruiting or not: 29% stop at 75 or younger and 23% at 65; 16% take children; 15% are for women only and <1% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Blood Loss, Surgical studies take

Of 24 phase 4 interventional studies under Blood Loss, Surgical, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 412 mo8–25 · 24 studies—12 mo8–25 · 24 studies
Interventional, no phase11 mo5–23 · 40 studies—11 mo5–25 · 31 studies
Observational12 mo7–60 · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Results posted2

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 213. Browse all 213 → or search them.